Black Rock Inc. Tempest Therapeutics, Inc. Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TPST
# of Institutions
35Shares Held
2.46MCall Options Held
44.9KPut Options Held
109K-
Altium Capital Management LP New York, NY545KShares$501,4000.27% of portfolio
-
Geode Capital Management, LLC Boston, MA220KShares$202,4610.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA176KShares$162,0970.0% of portfolio
-
Fil LTD Hamilton, D0130KShares$119,2120.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX106KShares$97,1520.03% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $9.59M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...